There are no major presentations of phase III clinical trial data at the European Association of Urology (EAU)
- Orteronel (TAK-700) fails in Advanced Prostate Cancer
- What is the potential for galeterone in advanced prostate cancer?
- Will dasatinib be effective in prostate cancer?
- ASCO 2012 What is the Optimal Sequencing of Advanced Prostate Cancer Drugs?
- Alpharadin Expanded Access Program is Recruiting #EAU12
- European Association of Urology 2012 #EAU12 Twitter Coverage
- ASCO GU: radium-233 Alpharadin significantly prolongs time to first Skeletal Related Event
- American Urological Association Annual Meeting 2011 Satellite Symposia
- Update from AACR on new prostate cancer drugs to watch